HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long noncoding RNA MIR3142HG accelerates lipopolysaccharide-induced acute lung injury via miR-95-5p/JAK2 axis.

Abstract
The study aims to clarify the expression pattern of MIR3142HG in acute lung injury (ALI) and investigate the potential mechanisms for the regulatory role of MIR3142HG in JAK/STAT in ALI. Notably, the ALI patients presented the overexpression of MIR3142HG and JAK2 in their serum samples. Knockdown of MIR3142HG facilitated cell viability but impaired cell apoptosis and inflammatory response via targeting miR-95-5p in lipopolysaccharide (LPS)-treated ALI cells. Overexpression of miR-95-5p promoted cell viability but suppressed apoptosis and inflammatory response via targeting JAK2 in LPS-induced ALI cells. The rescue experiments indicated that inhibition of miR-95-5p could reverse the increased cell viability and promote the inhibited apoptosis and inflammatory response induced by MIR3142HG knockdown in LPS-induced ALI. In conclusion, MIR3142HG is increased in sepsis-induced ALI, and MIR3142HG could accelerate the progression of sepsis-induced ALI through miR-95-5p/JAK2 axis, providing theoretical evidence for MIR3142HG to be a promising target for the therapeutics of ALI.
AuthorsYanqiu Gao, Shuangfeng Li, Rui Dong, Xiaoyan Li
JournalHuman cell (Hum Cell) Vol. 35 Issue 3 Pg. 856-870 (May 2022) ISSN: 1749-0774 [Electronic] Japan
PMID35277830 (Publication Type: Journal Article)
Copyright© 2022. The Author(s) under exclusive licence to Japan Human Cell Society.
Chemical References
  • Lipopolysaccharides
  • MIRN95 microRNA, human
  • MicroRNAs
  • RNA, Long Noncoding
  • JAK2 protein, human
  • Janus Kinase 2
Topics
  • Acute Lung Injury (chemically induced, genetics)
  • Apoptosis (genetics)
  • Humans
  • Janus Kinase 2 (genetics)
  • Lipopolysaccharides (adverse effects)
  • MicroRNAs (genetics, metabolism)
  • RNA, Long Noncoding (genetics)
  • Sepsis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: